Inhibition of MEK blocks GRP78 up-regulation and enhances apoptosis induced by ER stress in gastric cancer cells

Cancer Lett. 2009 Feb 8;274(1):40-6. doi: 10.1016/j.canlet.2008.08.030. Epub 2008 Oct 1.

Abstract

We studied potential interactions between the endoplasmic reticulum (ER) stress response and the MEK/ERK pathway. Induction of ER stress did not trigger significant apoptosis, but caused rapid activation of ERK1/2 in gastric cancer cells. Inhibition of MEK enhanced ER stress-induced apoptosis via a caspase-dependent, mitochondria-mediated mechanism. This was associated with blockage of ER stress-mediated up-regulation of GRP78. The latter appeared to be critical in antagonizing the apoptosis-inducing potential of ER stress. Thus, activation of MEK/ERK by ER stress is necessary for induction of GRP78 that protects against apoptosis in gastric cancer cells submitted to ER stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 6 / antagonists & inhibitors
  • Activating Transcription Factor 6 / genetics
  • Activating Transcription Factor 6 / metabolism
  • Adenocarcinoma / genetics
  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Antiviral Agents / pharmacology
  • Apoptosis*
  • Blotting, Western
  • Caspases / metabolism
  • Endoplasmic Reticulum / drug effects*
  • Endoplasmic Reticulum Chaperone BiP
  • Endoribonucleases / antagonists & inhibitors
  • Endoribonucleases / genetics
  • Endoribonucleases / metabolism
  • Enzyme Inhibitors / pharmacology
  • Heat-Shock Proteins / metabolism*
  • Humans
  • MAP Kinase Kinase 1 / antagonists & inhibitors*
  • MAP Kinase Kinase 1 / genetics
  • MAP Kinase Kinase 1 / metabolism
  • Membrane Potential, Mitochondrial / drug effects
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Molecular Chaperones / metabolism*
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • RNA, Small Interfering / pharmacology
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / pathology*
  • Thapsigargin / pharmacology
  • Tumor Cells, Cultured
  • Tunicamycin / pharmacology
  • Up-Regulation
  • eIF-2 Kinase / antagonists & inhibitors
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / metabolism

Substances

  • Activating Transcription Factor 6
  • Antiviral Agents
  • Endoplasmic Reticulum Chaperone BiP
  • Enzyme Inhibitors
  • HSPA5 protein, human
  • Heat-Shock Proteins
  • Molecular Chaperones
  • RNA, Small Interfering
  • Tunicamycin
  • Thapsigargin
  • ERN1 protein, human
  • PERK kinase
  • Protein Serine-Threonine Kinases
  • eIF-2 Kinase
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • MAP Kinase Kinase 1
  • MAP2K1 protein, human
  • Endoribonucleases
  • Caspases